Role of Propolis Endodontic Irrigant on Post-Operative Pain
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05974748 |
Recruitment Status :
Completed
First Posted : August 3, 2023
Last Update Posted : September 7, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The goal of this clinical trial is to compare propolis and sodium hypochlorite as endodontic irrigants in patients presenting with symptomatic irreversible pulpitis.
. The main question it aims to answer is:
• if there is any analgesic effects of 20% Propolis compared with 5.25% NaOCl on the intensity of post-operative pain in patients with symptomatic irreversible pulpitis using VAS pain score. Participants will undergo root canal treatment of their teeth using either 20% propolis solution or 5.25% NaOCl in their first visit of a multi-visit root canal treatment.
Researchers will compare 20% Propolis and 5.25% NaOCl to see reduction in Intensity of Post-Operative Pain using visual analogue scale over 72 hour duration.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Post-operative Pain Symptomatic Irreversible Pulpitis | Drug: Sodium hypochlorite 5.25% Drug: Propolis 20% | Phase 3 |
Sodium hypochlorite as an endodontic irrigant, poses problems of toxicity. Additionally, its unfavorable odor, taste, failure to remove the smear layer, and proteolytic effect have deleterious effects on the dentine, creating unfavorable structural and mechanical alterations . To get beyond NaOCl limits and adverse effects, it is necessary to look for a biocompatible, equally effective, and dentine friendly irrigant with greater patient acceptance in taste and odor.
The literature lacks an in-vivo study that investigates the anti-inflammatory with analgesic characteristics of Propolis on post-endodontic pain as an irrigant, in patients with symptomatic irreversible pulpitis. This research will endeavor to fill this gap in literature.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 44 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | 2 interventional groups assigned. 1 will be receiving routine intervention and other is the experimental group. |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | Participants will not be aware of their interventional group. A proforma and pain intensity scale will be provided to the patient by an intern not involved in the study, to be completed at 24, 48, and 72 hours following the procedure to assess post-operative pain. this proforma will be collected and assessed by the intern. |
Primary Purpose: | Prevention |
Official Title: | Comparative Evaluation of Propolis and Sodium Hypochlorite as Endodontic Irrigants on Post-Operative Pain in Patients With Symptomatic Irreversible Pulpitis |
Actual Study Start Date : | April 1, 2023 |
Actual Primary Completion Date : | August 15, 2023 |
Actual Study Completion Date : | August 15, 2023 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Sodium Hypochlorite
5.25% sodium hypochlorite is the gold standard endodontic irrigant. Other Name: NaOCl
|
Drug: Sodium hypochlorite 5.25%
The participants will be randomly divided into two groups using the sealed envelope method during the instrumentation process. The clinician will use the irrigation in accordance with the protocol. Between each instrument in group A, 3 ml of 5.25% sodium hypochlorite (NaOCl) will be used to irrigate each canal.
Other Name: NaOCl |
Experimental: Propolis
Hydroalcoholic 20% propolis will be used as an endodontic irrigant. Other Name: Bee glue
|
Drug: Propolis 20%
In group B, a 20% hydroalcoholic propolis solution of 3 milliliters will be used to irrigate each canal, between each instrument.
Other Name: Bee glue |
- Change in post-operative pain intensity on visual analogue scale(0-10) [ Time Frame: 24 hours, 48 hours and 72 hours ]Self recorded by patient and then assessed by an intern on a visual analogue scale of 0-10 with 0 being no pain , 10 being worst pain
- Need of rescue medicine in both groups [ Time Frame: within first 24 hours ]Self recorded by patient and then assessed by an intern on a visual analogue scale of 0-10 with 0 being no pain , 10 being worst pain
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- ASA-I and II individuals who are between the ages of 18 and 60 years.
- Patients with mandibular and maxillary premolars who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis).
- Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS=1-10)
Exclusion Criteria:
- Patients suffering from severe pain because of traumatic occlusion.
- Teeth with extensive damage, calcified canals, periapical radiolucency, root resorption, and an open apex.
- Patients with compromised medical condition (ASA-III and above)
- Patients who are unable to communicate effectively in either Urdu or English.
- Pregnant and lactating ladies
- Patients who are allergic to honey or bee pollen.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05974748
Pakistan | |
Dow International Dental College | |
Karachi, Sindh, Pakistan, 75500 |
Principal Investigator: | Tayyaba Tahira, BDS FCPS | Dow International Dental College, Dow University of Health Sciences | |
Study Director: | Farah Naz, BDS FCPS | Dow International Dental College, Dow University of Health Sciences |
Responsible Party: | Tayyaba Tahira, Lecturer, Dow University of Health Sciences |
ClinicalTrials.gov Identifier: | NCT05974748 |
Other Study ID Numbers: |
2908 |
First Posted: | August 3, 2023 Key Record Dates |
Last Update Posted: | September 7, 2023 |
Last Verified: | September 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Only investigators and co-investigators of this study will be able to access to participants' personal data. Ownership of the data will remain with the principal investigator and Department of Operative Dentistry, Dow International Dental College(DIDC) , Dow University of Health Sciences |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Propolis Endodontic Irrigant |
Pulpitis Pain, Postoperative Postoperative Complications Pathologic Processes Pain Neurologic Manifestations Dental Pulp Diseases |
Tooth Diseases Stomatognathic Diseases Propolis Sodium Hypochlorite Eusol Anti-Infective Agents Disinfectants |